Arpey, MD, there is no single best approach to treating lentigo maligna (LM ... LM and LMM comprise about 10% of all cases of malignant melanoma, with a rising incidence as documented by ...

Lentigo maligna melanoma is a melanoma in situ on sun-damaged ... It accounts for 4% to 15% of all malignant melanomas (Koh et al., 1984; Little, Holt, & Davis, 1980; McGovern, Shaw, Milton ...

2 This melanocyte hyperplasia can be benign (nevi and lentigo) or malignant (nail melanoma). Tumoral lesions such as onychomatricoma, onychocytic matricoma, onicopapilloma, and Bowen's disease can ...

malignant melanoma in precancerous melanosis, lentigo malignant melanoma, superficial spreading melanoma, acral lentiginous melanoma, desmoplastic melanoma, and mucosal lentiginous melanoma], and 8761 ...

The following is a summary of “Primary acquired melanosis with spill over periocular lentigo maligna: 19-year outcomes at a specialist eyelid and ocular oncology centre,” published in the February ...

My 36-year-old sister recently noticed an unusual mole on her shoulder. She is scheduled for some tests. Her primary care ...

The failure in adjuvant melanoma could cause BMS and Opdualag to miss out on a market opportunity that is nearly twice as ...

Researchers have identified a key role microglia play in melanoma brain metastases progression and mechanisms to target them.

IEO and Politecnico di Milano have developed a “gut-on-chip” capable of predicting the response to immunotherapy in patients ...

Melanoma is one of the most aggressive skin cancers, with over 300,000 new cases reported worldwide each year. In Europe, the number of diagnoses has been rising rapidly.

During a Case-Based Roundtable® event, Evan J. Lipson, MD, moderated a discussion on the tolerability of immunotherapy in ...